Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings from F.O. Ademuyiwa et al in breast cancer reported
February 26th, 2009
"Angiogenesis plays a central role in the development of metastasis in breast cancer," scientists writing in the journal Clinical Breast Cancer report. "Recent results of large randomized trials show clinically significant improvements in outcomes with the use of bevacizumab in patients with metastatic breast cancer, leading to approval by European and US regulatory agencies. Several other antiangiogenic strategies are in various stages of development," wrote F.O. Ademuyiwa and colleagues. The researchers concluded: "This review discusses the results of recent clinical trials and novel mechanisms of inhibiting angiogenesis, resistance...
Source: Women's Health Weekly (2009-02-26)
|
